{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:09:34Z","timestamp":1792292974679,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ymgme.2014.08.011","type":"journal-article","created":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T00:38:45Z","timestamp":1409618325000},"page":"233-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11years of therapy: Clinical, histopathologic, and biochemical findings"],"prefix":"10.1016","volume":"114","author":[{"given":"Thomas A.","family":"Burrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve W.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D.R.","family":"Setchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.08.011_bb0005","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Gaucher disease","author":"Grabowski","year":"2010"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2006.10.062","article-title":"Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy","volume":"150","author":"Burrow","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(98)90023-6","article-title":"Enzyme therapy for Gaucher disease: the first 5years","volume":"12","author":"Grabowski","year":"1998","journal-title":"Blood Rev."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ajmg.a.10029","article-title":"Gaucher disease: in vivo evidence for allele dose leading to neuronopathic and nonneuronopathic phenotypes","volume":"116A","author":"Zhao","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0030","first-page":"179","article-title":"Gaucher disease: four families with previously undescribed mutations","volume":"108","author":"Beutler","year":"1996","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0035","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/hmg\/ddu105","article-title":"Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice","volume":"23","author":"Xu","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0040","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/hmg\/ddt096","article-title":"Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice","volume":"22","author":"Sun","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0045","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1194\/jlr.M500202-JLR200","article-title":"Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants","volume":"46","author":"Sun","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-2275(20)36896-6","article-title":"Determination of cholesterol using o-phthalaldehyde","volume":"14","author":"Rudel","year":"1973","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0055","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tins.2004.01.007","article-title":"More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases","volume":"27","author":"Lee","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0065","series-title":"Gaucher Disease","first-page":"225","article-title":"Neuropathological aspects of Gaucher disease","author":"Wong","year":"2007"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"Xu","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1471-4159.1982.tb07950.x","article-title":"Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease","volume":"39","author":"Nilsson","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00690463","article-title":"Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies","volume":"65","author":"Conradi","year":"1984","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1399-0004.1985.tb00229.x","article-title":"Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants","volume":"27","author":"Nilsson","year":"1985","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0090","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00247-002-0761-0","article-title":"Mesenteric mass in a young girl\u2014an unusual site for Gaucher's disease","volume":"32","author":"Lim","year":"2002","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-2008-1071549","article-title":"Enzyme replacement therapy of infantile Gaucher disease","volume":"24","author":"Erikson","year":"1993","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0100","series-title":"Gaucher Disease: A Century of Delineation and Research","first-page":"177","article-title":"Pathology of Gaucher disease","author":"Lee","year":"1982"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0105","series-title":"Gaucher Disease","first-page":"197","article-title":"Pathologic anatomy of Gaucher disease: a pictorial essay","author":"Lee","year":"2007"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00687792","article-title":"Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease","volume":"75","author":"Conradi","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood\u2013brain barrier disorder in Alzheimer's disease","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.3276004","article-title":"Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo","volume":"239","author":"Hickey","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0130","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1172\/JCI29683","article-title":"Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy","volume":"116","author":"Ritter","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuron.2009.11.032","article-title":"Dual roles for perivascular macrophages in immune-to-brain signaling","volume":"65","author":"Serrats","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0092-8674(78)90102-2","article-title":"Human beta-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells","volume":"15","author":"Achord","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0304-4165(81)90474-8","article-title":"Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation","volume":"673","author":"Furbish","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0150","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1172\/JCI116409","article-title":"Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages","volume":"91","author":"Sato","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1212\/01.wnl.0000247744.10990.e6","article-title":"Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease","volume":"68","author":"Lonser","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1529-8027.2009.00217.x","article-title":"Schwann cells express the macrophage mannose receptor and MHC class II. Do they have a role in antigen presentation?","volume":"14","author":"Baetas-da-Cruz","year":"2009","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/glia.10196","article-title":"Functional characterization of mannose receptor expressed by immunocompetent mouse microglia","volume":"42","author":"Zimmer","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s004410000311","article-title":"Regional and cellular expression of the mannose receptor in the post-natal developing mouse brain","volume":"303","author":"Burudi","year":"2001","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0175","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.176.1.287","article-title":"Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation","volume":"176","author":"Stein","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0180","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood.V80.9.2363.bloodjournal8092363","article-title":"Characterization of the murine macrophage mannose receptor: demonstration that the downregulation of receptor expression mediated by interferon-gamma occurs at the level of transcription","volume":"80","author":"Harris","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/8904_2011_48","article-title":"A twelve-year follow-up study on a case of early-onset parkinsonism preceding clinical manifestation of Gaucher disease","volume":"3","author":"Machaczka","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0195","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2014.08.011_bb0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0205","series-title":"News and Events","article-title":"FDA approves new drug to treat a form of Gaucher disease","year":"2014"},{"key":"10.1016\/j.ymgme.2014.08.011_bb0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10545-010-9072-z","article-title":"Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy","volume":"33","author":"Marshall","year":"2010","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214002765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214002765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T02:34:21Z","timestamp":1650076461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214002765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1096719214002765"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.08.011","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11years of therapy: Clinical, histopathologic, and biochemical findings","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}